GlassScriptPhysician profile
Charles Wesley Ford
NPI 1164481727
$2,151.24
in general payments reported to CMS, 2019-2025
19 companies · $784 in 2025
The $784 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $216 · 2021: $223 · 2022: $113 · 2023: $347 · 2024: $168 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,299.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $521.95 | 2019-2025 | Dupixent |
| Genzyme Corporation | $387.18 | 2020-2025 | |
| Alk-Abello, INC | $195.74 | 2019-2022 | |
| Stryker Corporation | $194.25 | 2019-2023 | Xpress Ent Dilation System |
| Optinose US, INC. | $177.33 | 2020-2025 | |
| Ars Pharmaceuticals Operations, INC. | $123.31 | 2025 | Neffy |
| Kaleo, INC. | $123.20 | 2019-2022 | |
| Glaxosmithkline, LLC. | $102.24 | 2024-2025 | Nucala |
| Abbvie INC. | $62.40 | 2019-2023 | |
| Acclarent, INC | $42.33 | 2021 | |
| Inspire Medical Systems, INC. | $41.67 | 2023-2025 | Inspire |
| Aytu Biopharma, INC. | $36.47 | 2019 | |
| Tactile Systems Technology INC | $32.34 | 2021-2023 | Flexitouch Plus, Entre Plus |
| Astrazeneca Pharmaceuticals LP | $28.12 | 2025 | Tezspire |
| Medtronic, INC. | $19.00 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.67 | 2025 | Xolair |
| Aerin Medical INC. | $16.16 | 2019 | |
| Intersect Ent, INC. | $15.56 | 2019 | |
| Phathom Pharmaceuticals, INC. | $13.32 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.